| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.07 |